Delivery Order SPE2DB24D2003-SPE2DB25FXJT5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for OFEV (nintedanib) 150 mg capsules (60-count units) on July 18, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order represents a non-set-aside award, indicating it was competitively procured. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order is...
- The Defense Logistics Agency awarded a $8,590.58 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of OFEV 150 mg capsules (60-unit quantity). The contract, which is non-set-aside and competitively awarded, represents a firm fixed-price delivery order with an ultimate completion date of August 4, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of OFEV 150 mg capsules (60 count) with a ceiling value of $8,590.58. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of OFEV 150 mg capsules (60-count units) valued at $8,590.58 with a completion date of October 10, 2025. This is a firm fixed-price, non-set-aside contract delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive global pharmaceutical support vehicle running through December...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,590.58 for OFEV 150 mg capsule 60-count units on August 4, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of OFEV (nintedanib) 150 mg capsules in a quantity of 60 units, with a ceiling value of $8,590.58. This is a firm fixed price delivery order with no set-aside designation, representing a competitive award to the prime contractor. The order is scheduled for completion by August 11, 2025, with performance taking place at the vendor's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count units) on August 19, 2025, with completion targeted for September 10, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of OFEV 100 mg capsules (60-count units) valued at $8,630.28 with a firm fixed-price structure. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The work will be performed at the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for OFEV (nintedanib) 150 mg capsules (60-count unit) on September 18, 2025, with an ultimate completion date of October 9, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen, a major pharmaceutical distributor and critical federal medical procurement vendor,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of OFEV (nintedanib) 150 mg capsules in quantities of 60 units. This contract was competitively awarded on August 18, 2025, with a ceiling value of $17,181.16 and a firm fixed price structure. The delivery order is scheduled for completion by September 9, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. No small business set-aside designation was...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXJT5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of OFEV (nintedanib) 100 mg capsules in a 60-count package, with a contract ceiling value of $8,630.28 and a firm fixed-price structure. This is an unset-aside competitive award that serves as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order is scheduled for completion by July 9, 2025, with performance conducted at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, fulfills a critical role in the federal medical supply chain serving military and veteran healthcare systems. The company's comprehensive IDC with DLA enables the supply of a broad portfolio of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities across multiple therapeutic areas to support Defense Health Agency operations and other federal healthcare customers globally. This particular delivery order for OFEV, a pulmonary fibrosis medication, exemplifies the company's ongoing role in meeting specialized pharmaceutical procurement needs for the Department of Defense medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 6/16/25 |